CSE: 2018-0523 – New Listing – Resinco Capital Partners Inc. (RIN)


The common shares of Resinco Capital Partners Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Resinco Capital Partners is a global investment company which specializes in providing early stage financing to private and public companies. The Company engages in new, early stage investment opportunities in previously underdeveloped assets and obtaining significant position in early stage investment opportunities that adequately reflect the risk profile.


Les actions ordinaires de Resinco Capital Partners Inc. ont été approuvées pour inscription à la cote du CSE.

Les documents d’inscription et de divulgation seront disponibles sur www.thecse.com à la date de négociation.

Resinco Capital Partners est une société d’investissement internationale spécialisée dans le financement de projets en début de croissance auprès d’entreprises privées et publiques. La Société s’engage dans de nouvelles opportunités d’investissement dans des actifs précédemment sous-développés et obtient une position significative dans des opportunités d’investissement à un stade précoce reflétant adéquatement le profil de risque.

Issuer/Émetteur: Resinco Capital Partners Inc.
Security Type/Titre: Common Shares/Actions ordinaires 
Symbol(s)/Symbole(s): RIN
Number of securities issued and outstanding/ Titres émis et en circulation: 46 141 007
Number of Securities reserved for issuance/ Titres réservés pour émission: 34 057 955
CSE Sector/Catégorie: Diversified Industries/Sociétés diversifiées
CUSIP:  76112T 20 0
ISIN: CA 76112T 20 0 2
Boardlot/Quotité: TBD
Trading Currency/Monnaie de négociation: CDN$/$CDN
Trading Date/Date de negociation: Le 28 mai/May 2018
Other Exchanges/Autres marches: N/A
Fiscal Year end /Clôture de l’exercice financier: December 31/Le 31 décembre
Transfer Agent/Agent des transferts: Computershare Investor Services Inc.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com

Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:  Listings@thecse.com

Primary Logo

HighPoint Wins 2018 Corporate Growth Award

Reston, VA, May 24, 2018 (GLOBE NEWSWIRE) — HighPoint Global’s acquisition of Primescape Solutions has been named the winner in the 2018 Corporate Growth Awards in the category of Deal of the Year Under $50 Million.

HighPoint’s acquisition was identified as the most successful and impactful deal executed in the greater D.C. business community this year by the 2018 Corporate Growth Awards Committee. The award was presented at a black-tie gala on May 22, 2018.

HighPoint CEO, Ben Lanius accepts the award for Deal of the Year Under $50 Million.

HighPoint’s acquisition of Primescape added digital transformation services to HighPoint’s citizen experience expertise (CX). The combined company continues to provide support for the full range of citizen touchpoints with government including websites, mobile apps, video, social media, and call centers.

“Every year, ACG National Capital receives over a hundred nominations for its Corporate Growth Awards,” said Marc Marlin, the 2018 Corporate Growth Awards Committee Chair and a Managing Director at KippsDeSanto & Co. “Of these exceptional nominees, it’s exciting to celebrate and recognize some of the region’s fastest growing and most successful businesses and deal teams. HighPoint/Primescape was truly one of the best deals executed in the region in 2017.”

The ACG National Capital Corporate Growth Awards recognize the enterprises and individuals in the greater Washington, D.C. metro area’s business community that have exhibited excellence in corporate growth and dealmaking over the past year.

“I am thrilled that we were recognized by ACG for the strategy behind the Primescape acquisition and the benefits to our government customers,” said Ben Lanius, CEO of HighPoint. “The success of the companies separately, and now as a joint entity, is entirely due to the dedication of our team and ensures customer and citizen needs are understood and met every step of the way.”


About HighPoint

HighPoint helps government agencies elevate the citizen experienceTM by improving the touchpoints through which citizens interact with government. From contact centers and employee experience to digital and data services, our team works with government agencies to more efficiently integrate the people, processes and technology that help government deliver on the needs of citizens and employees. HighPoint delivers services for 15 government clients including the Centers for Medicare and Medicaid Services, Office of the Comptroller of Currency, Department of State, Defense Logistics Agency and Department of Housing and Urban Development.

HighPoint is a privately held company founded in 2006 with 350 employees across offices in Indianapolis, Indiana; Baltimore, Maryland; and Reston and Herndon, Virginia. For additional information about HighPoint, visit www.highpointglobal.com


About ACG National Capital

ACG National Capital, a chapter of the international association, ACG (Association for Corporate Growth) that serves Washington, D.C., northern Virginia and southern Maryland, drives middle-market growth and increases deal flow. It provides unparalleled opportunities for networking, deal making and professional development for individuals involved in building corporate value through M&A, strategic partnerships, organic growth and capital funding.

ACG National Capital’s veteran leadership and its membership have participated in nearly every M&A transaction completed recently in the D.C. metro region with over 400 members. For more information, visit www.acgcapital.org or the ACG online publication at www.acgcapitalblog.com.


Kim Miller
HighPoint Global

SHAREHOLDER ALERT – Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Myriad Genetics, Inc. (MYGN) & Lead Plaintiff Deadline: June 19, 2018

NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ:MYGN) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Myriad securities between August 13, 2014, and March 12, 2018, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: http://www.bgandg.com/mygn.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Myriad was submitting false or otherwise improper claims for payment under Medicare and Medicaid for the Company’s hereditary cancer testing; (2) the foregoing conduct would foreseeably subject Myriad to heightened regulatory scrutiny and/or enforcement action; (3) Myriad’s revenues from its hereditary cancer testing were in part the product of improper conduct and unlikely to be sustainable; and (4) as a result, Myriad’s public statements were materially false and misleading at all relevant times.

On March 12, 2018, post-market, Myriad disclosed that it had received a subpoena from the Department of Health and Human Services, Office of Inspector General, in connection with “an investigation into possible false or otherwise improper claims submitted for payment under Medicare and Medicaid,” specifically relating to Myriad’s hereditary cancer testing.  The subpoena covers a time period from January 1, 2014—less than four months after the September 2013 launch of Myriad’s myRisk test—through the date of the subpoena’s issuance. Following this news, Myriad stock dropped $4.01 per share, or 12.14%, to close at $29.01 on March 13, 2018.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/mygn or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Myriad you have until June 19, 2018 to request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique.  Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients.  In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration.   Attorney advertising. Prior results do not guarantee similar outcomes.

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

Primary Logo